chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: A spontaneous report was received from a healthcare professional concerning a 77-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events fever 100.6, bodyaches.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 12 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 12 Feb 2021, the patient experienced the event(s) fever 100.6 . On 12 Feb 2021, the patient experienced the event(s) bodyaches.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), fever 100.6 was unknown.The outcome of event(s), bodyaches was unknown..
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Pain, Pyrexia
Clinical narrative: Redness around the injection site; Pain; Chills a fever of 100; Chills a fever of 100; Muscle aches; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), PYREXIA (Chills a fever of 100), CHILLS (Chills a fever of 100), MYALGIA (Muscle aches) and FATIGUE (Fatigue) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2021, the patient experienced PAIN (Pain), PYREXIA (Chills a fever of 100), CHILLS (Chills a fever of 100), MYALGIA (Muscle aches) and FATIGUE (Fatigue). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Redness around the injection site). On 15-Feb-2021, PYREXIA (Chills a fever of 100), CHILLS (Chills a fever of 100), MYALGIA (Muscle aches) and FATIGUE (Fatigue) had resolved. At the time of the report, PAIN (Pain) and VACCINATION SITE ERYTHEMA (Redness around the injection site) had not resolved.            No Concomitant product use was reported.  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not applicable.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Redness around the injection site; Pain; Chills a fever of 100; Chills a fever of 100; Muscle aches; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), PYREXIA (Chills a fever of 100), CHILLS (Chills a fever of 100), MYALGIA (Muscle aches) and FATIGUE (Fatigue) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2021, the patient experienced PAIN (Pain), PYREXIA (Chills a fever of 100), CHILLS (Chills a fever of 100), MYALGIA (Muscle aches) and FATIGUE (Fatigue). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Redness around the injection site). On 15-Feb-2021, PYREXIA (Chills a fever of 100), CHILLS (Chills a fever of 100), MYALGIA (Muscle aches) and FATIGUE (Fatigue) had resolved. At the time of the report, PAIN (Pain) and VACCINATION SITE ERYTHEMA (Redness around the injection site) had not resolved.            No Concomitant product use was reported.  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not applicable.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Blood cholesterol, Fatigue, Herpes zoster, Pain
Clinical narrative: Shingles; Mild to moderate achiness; Tiredness; Abdominal pain; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (Abdominal pain), HERPES ZOSTER (Shingles), PAIN (Mild to moderate achiness) and FATIGUE (Tiredness) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol high (No medical history reported), Macular degeneration and Cold sores. Concomitant products included ATORVASTATIN CALCIUM (LIPITOR), ASCORBIC ACID, TOCOPHERYL ACETATE, XANTOFYL, ZEAXANTHIN, ZINC (AREDS), APOAEQUORIN (PREVAGEN [APOAEQUORIN]) and L-LYSINE [LYSINE] for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced ABDOMINAL PAIN (Abdominal pain), PAIN (Mild to moderate achiness) and FATIGUE (Tiredness). On 06-Feb-2021, the patient experienced HERPES ZOSTER (Shingles). At the time of the report, ABDOMINAL PAIN (Abdominal pain), HERPES ZOSTER (Shingles), PAIN (Mild to moderate achiness) and FATIGUE (Tiredness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood cholesterol: high (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant Medication: Centrum Silver Vitamin   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Non-significant TCR FU - Consent declined.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: Muscle pain; Headache; A spontaneous report was received from a healthcare professional concerning a 65-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events muscle pain, sporadic headaches.  The patient's medical history was Type 2 diabetes, high blood pressure, arthritis, chronic gastritis and diverticulitis. His Concomitant medications reported were Gabapentin 300mg for drug use for unknown indication.  On 29 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 011120A) via unknown route for prophylaxis of COVID-19 infection.  On 29 Jan 2021, the patient experienced the event(s) muscle pain, sporadic headaches and he took Tylenol and Advil to treat his symptoms.     Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), muscle pain, sporadic headaches was unknown.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain, Pyrexia
Clinical narrative: she hurts all over; fever of 101.8 Deg. F; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (she hurts all over), PYREXIA (fever of 101.8 Deg. F) and CHILLS (Chills) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2021, the patient experienced PAIN (she hurts all over), PYREXIA (fever of 101.8 Deg. F) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) (oral) at an unspecified dose and frequency. At the time of the report, PAIN (she hurts all over), PYREXIA (fever of 101.8 Deg. F) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Feb-2021, Body temperature: 101.8 (High) 101.8 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Erythema, Injection site swelling, Pruritus
Clinical narrative: Itching; Burning; Swollen at the injection site; The area is red; A spontaneous report was received from a healthcare professional concerning a 74-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events itching, burning, swollen at the injection site, swollen under the arm pit, the area is red.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 13 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Not provided) intramuscularly for prophylaxis of COVID-19 infection.  On 13 Feb 2021, the patient experienced the event(s) itching . On 13 Feb 2021, the patient experienced the event(s) burning . On 13 Feb 2021, the patient experienced the event(s) swollen at the injection site . On 13 Feb 2021, the patient experienced the event(s) swollen under the arm pit . On 13 Feb 2021, the patient experienced the event(s) the area is red.  Treatment details included Benadryl, Icepack.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), itching was unknown.The outcome of event(s), burning was unknown.The outcome of event(s), swollen at the injection site was unknown.The outcome of event(s), swollen under the arm pit was unknown.The outcome of event(s), the area is red was unknown..
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative, Upper respiratory tract infection
Clinical narrative: Upper respiratory infection; This spontaneous case was reported by a consumer and describes the occurrence of UPPER RESPIRATORY TRACT INFECTION (Upper respiratory infection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced UPPER RESPIRATORY TRACT INFECTION (Upper respiratory infection). At the time of the report, UPPER RESPIRATORY TRACT INFECTION (Upper respiratory infection) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test negative: negative (Negative) negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Nasopharyngitis, Oropharyngeal pain, Pain in extremity, Rhinorrhoea
Clinical narrative: cold; Runny nose; sore throat; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold), RHINORRHOEA (Runny nose), OROPHARYNGEAL PAIN (sore throat) and PAIN IN EXTREMITY (sore arm) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced NASOPHARYNGITIS (cold), RHINORRHOEA (Runny nose), OROPHARYNGEAL PAIN (sore throat) and PAIN IN EXTREMITY (sore arm). At the time of the report, NASOPHARYNGITIS (cold), RHINORRHOEA (Runny nose), OROPHARYNGEAL PAIN (sore throat) and PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient stated that he has never had a cold in the winter before.No concomitant medications were reported.No treatment information was provided.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood glucose increased, Vomiting
Clinical narrative: blood sugar is little high; feels weak; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (blood sugar is little high), ASTHENIA (feels weak) and VOMITING (vomiting) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced BLOOD GLUCOSE INCREASED (blood sugar is little high), ASTHENIA (feels weak) and VOMITING (vomiting). At the time of the report, BLOOD GLUCOSE INCREASED (blood sugar is little high), ASTHENIA (feels weak) and VOMITING (vomiting) outcome was unknown.            The patient's relevant concomitant medications weren't reported Treatment information was not provided
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Hives (Patient was prone to hives several months before receiving vaccine.). On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jan-2021, the patient experienced URTICARIA (Hives). At the time of the report, URTICARIA (Hives) outcome was unknown. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. Concomitant product use was not provided by the reporter. The patient went to seek medical advice from her allergist and decided to receive the second dose and the hives worsened after the second dose, patient went to emergency room on 14 Feb 2021. The doctor wanted to administer the steroid. No treatment information was provided.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood glucose increased, Vomiting
Clinical narrative: blood sugar is little high; feels weak; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (blood sugar is little high), ASTHENIA (feels weak) and VOMITING (vomiting) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced BLOOD GLUCOSE INCREASED (blood sugar is little high), ASTHENIA (feels weak) and VOMITING (vomiting). At the time of the report, BLOOD GLUCOSE INCREASED (blood sugar is little high), ASTHENIA (feels weak) and VOMITING (vomiting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose increased: high (High) blood sugar is little high.         Action taken with mRNA-1273 in response to the drug was not applicable. No concomitant medication information was provided. No treatment medication information was provided.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis, Pain, Pain in extremity, Pyrexia
Clinical narrative: sore arm; nosebleed; achy; had a fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), EPISTAXIS (nosebleed), PAIN (achy) and PYREXIA (had a fever) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm), EPISTAXIS (nosebleed), PAIN (achy) and PYREXIA (had a fever). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. On 14-Feb-2021, PYREXIA (had a fever) had resolved. At the time of the report, PAIN IN EXTREMITY (sore arm), EPISTAXIS (nosebleed) and PAIN (achy) outcome was unknown.            No concomitant medication was reported. Treatment medication included antidepressants Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain
Clinical narrative: soreness at injection site; injection site redness; This spontaneous case was reported by a consumer and describes the occurrence of   in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L20A and 062620A) for COVID-19 vaccination.     The patient's past medical history included Pacemaker complication and Hypothyroidism. Concurrent medical conditions included Seasonal allergy and Constipation. Concomitant products included LEVOTHYROXINE, LUBIPROSTONE (AMITIZA), SODIUM CHLORIDE and ATORVASTATIN for an unknown indication.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form.            Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site rash
Clinical narrative: pain in arm; COVID arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in arm) and VACCINATION SITE RASH (COVID arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 032L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included VITAMINS NOS, TURMERIC [CURCUMA LONGA RHIZOME] and METFORMIN for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Jan-2021, the patient experienced PAIN IN EXTREMITY (pain in arm) and VACCINATION SITE RASH (COVID arm). At the time of the report, PAIN IN EXTREMITY (pain in arm) and VACCINATION SITE RASH (COVID arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment information were not provided by the reporter.   This case was linked to MOD-2021-039236 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2021: Follow-up received contains no new information. On 10-Aug-2021: Follow-up received contains no new information.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Lip swelling, Mass, Pruritus, Urticaria
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (Lip swollen), PRURITUS (Entire body was itchy), MASS (Lump size of an orange between legs, one on each) and URTICARIA (Hives all over the body) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 025J20-2A) for COVID-19 vaccination. No Medical History information was reported. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced LIP SWELLING (Lip swollen), PRURITUS (Entire body was itchy), MASS (Lump size of an orange between legs, one on each) and URTICARIA (Hives all over the body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1-2 times, qd. At the time of the report, LIP SWELLING (Lip swollen), PRURITUS (Entire body was itchy), MASS (Lump size of an orange between legs, one on each) and URTICARIA (Hives all over the body) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, Blood pressure measurement: 164/104 (Inconclusive) BP 164/104. Treatment include steroids, antihistamines. Concomitant medication information not provided by the reporter. Action taken with mRNA-1273 in response to the event was not applicable. This case was linked to MOD-2021-044626.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Illness
Clinical narrative: Fatigue; Punk; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) and ILLNESS (Punk) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included METHYLPREDNISOLONE for Asthma.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced FATIGUE (Fatigue) and ILLNESS (Punk). At the time of the report, FATIGUE (Fatigue) and ILLNESS (Punk) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information were reported.    Reporter did not allow further contact
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Haematoma, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Hematoma; Vaccination site burning; Vaccination site erythema; Vaccination site pruritus; This spontaneous case was reported by a consumer and describes the occurrence of HAEMATOMA (Hematoma ), VACCINATION SITE PAIN (Vaccination site burning), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and VACCINATION SITE PRURITUS (Vaccination site pruritus) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04LL20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HAEMATOMA (Hematoma ), VACCINATION SITE PAIN (Vaccination site burning), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and VACCINATION SITE PRURITUS (Vaccination site pruritus). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form; NAPROXEN SODIUM (ALEVE) at a dose of 1 dosage form and HYDROCORTISONE at a dose of 1 dosage form. At the time of the report, HAEMATOMA (Hematoma ), VACCINATION SITE PAIN (Vaccination site burning), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and VACCINATION SITE PRURITUS (Vaccination site pruritus) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were provided.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy, Rash, Rash erythematous, Rash papular, Viral rash
Clinical narrative: Red rash; Raised rash; Viral rash; Painful rash; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of RASH ERYTHEMATOUS (Red rash), RASH PAPULAR (Raised rash), VIRAL RASH (Viral rash) and RASH (Painful rash) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced RASH ERYTHEMATOUS (Red rash), RASH PAPULAR (Raised rash), VIRAL RASH (Viral rash) and RASH (Painful rash). The patient was treated with PREDNISONE (oral) for Symptomatic treatment, at a dose of Took it for 2 days. In February 2021, VIRAL RASH (Viral rash) and RASH (Painful rash) had resolved. At the time of the report, RASH ERYTHEMATOUS (Red rash) and RASH PAPULAR (Raised rash) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Biopsy: inconclusive (Inconclusive) Biopsy which showed viral rash.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: No newinformation was provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Mobility decreased, Pain in extremity
Clinical narrative: Extreme pain in left arm; Patient could not use or lift her left arm; Sensitivity and pain in top of head; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Extreme pain in left arm), MOBILITY DECREASED (Patient could not use or lift her left arm) and HEADACHE (Sensitivity and pain in top of head) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN IN EXTREMITY (Extreme pain in left arm), MOBILITY DECREASED (Patient could not use or lift her left arm) and HEADACHE (Sensitivity and pain in top of head). At the time of the report, PAIN IN EXTREMITY (Extreme pain in left arm), MOBILITY DECREASED (Patient could not use or lift her left arm) and HEADACHE (Sensitivity and pain in top of head) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Follow up received on 22-JUN-2021 and contain no new information.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DIARRHEA (severe diarrhea) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0165M20A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included ATORVASTATIN, FERROUS SULFATE, LISINOPRIL, OXYBUTYNIN CHLORIDE, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and PANTOPRAZOLE for an unknown indication. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced DIARRHEA (severe diarrhea). At the time of the report, DIARRHEA (severe diarrhea) had resolved. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable. Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Follow up received and added second dose information, updated action taken(changed to not applicable) and event outcome (changed to resolved).
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of myalgia (arm soreness) and headache in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 vaccination. Concomitant products included Dicycton and multivitamins & minerals plus Lutein for an unknown indication. On Feb 12, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Feb 12, 2021, patient experienced myalgia (arm soreness) and headache. The patient was treated with Tylenol (paracetamol) ongoing since an unknown date for blood pressure, at an unspecified dose and frequency. At the time of the report, myalgia (arm soreness) and headache outcome unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscularly unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site swelling
Clinical narrative: been experiencing excruciating pain on the opposite side of the vaccination site; there is a bit of swelling; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (been experiencing excruciating pain on the opposite side of the vaccination site) and VACCINATION SITE SWELLING (there is a bit of swelling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced PAIN IN EXTREMITY (been experiencing excruciating pain on the opposite side of the vaccination site) and VACCINATION SITE SWELLING (there is a bit of swelling). At the time of the report, PAIN IN EXTREMITY (been experiencing excruciating pain on the opposite side of the vaccination site) and VACCINATION SITE SWELLING (there is a bit of swelling) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Fatigue, Nausea, Pyrexia
Clinical narrative: constantly coughing; fatigue; low grade fever; felt nauseous; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (constantly coughing), FATIGUE (fatigue), PYREXIA (low grade fever) and NAUSEA (felt nauseous) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20-2A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Shingles and Cough. Concomitant products included BENZONATATE for Cough, NIFEDIPINE for Hypertension, GABAPENTIN (GABAPENTIN "PCD") for Shingles, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced COUGH (constantly coughing), FATIGUE (fatigue), PYREXIA (low grade fever) and NAUSEA (felt nauseous). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN (CORICIDIN HBP CHEST CONGESTION & COUGH) for Cough, at an unspecified dose and frequency. At the time of the report, COUGH (constantly coughing), FATIGUE (fatigue), PYREXIA (low grade fever) and NAUSEA (felt nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included multivitamins for immunity and aspirin for blood thinner.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Diarrhoea, Headache, Injection site pain
Clinical narrative: Cough; Diarrhea; Headache; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of   in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment information was provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Palpitations
Clinical narrative: Heart palpitations; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches) and PALPITATIONS (Heart palpitations) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced PAIN (Body aches). On 10-Feb-2021, the patient experienced PALPITATIONS (Heart palpitations). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (Body aches) and PALPITATIONS (Heart palpitations) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant products were reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site rash, Injection site warmth, Pain in extremity
Clinical narrative: Injection site warm to touch; Bright red rash close to injection site; Injection site aching; Soreness of arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness of arm), INJECTION SITE WARMTH (Injection site warm to touch), INJECTION SITE RASH (Bright red rash close to injection site) and INJECTION SITE PAIN (Injection site aching) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (Soreness of arm). On 14-Feb-2021, the patient experienced INJECTION SITE WARMTH (Injection site warm to touch), INJECTION SITE RASH (Bright red rash close to injection site) and INJECTION SITE PAIN (Injection site aching). At the time of the report, PAIN IN EXTREMITY (Soreness of arm) had resolved and INJECTION SITE WARMTH (Injection site warm to touch), INJECTION SITE RASH (Bright red rash close to injection site) and INJECTION SITE PAIN (Injection site aching) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Her doctor told her to take Prednisone 20 mg three times daily and Generic Bactrim 1 tablet twice per day.  Her doctor also asked her to call Moderna regarding treatment recommendation regarding her side effects. She thought  the 60 mg of Prednisone is too much for her to take. No concomitant medications reported by investigator
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle twitching, Paraesthesia
Clinical narrative: This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (tingling in face / Tingling feet / Tingling hands) and MUSCLE TWITCHING (twinkling her left side of her face and also her breast) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS and CALCIUM for an unknown indication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced MUSCLE TWITCHING (twinkling her left side of her face and also her breast). On an unknown date, the patient experienced PARAESTHESIA (tingling in face / Tingling feet / Tingling hands). The patient was treated with Physical therapy for Paraesthesia. At the time of the report, PARAESTHESIA (tingling in face / Tingling feet / Tingling hands) had not resolved and MUSCLE TWITCHING (twinkling her left side of her face and also her breast) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: New AER tingling in face/hands/feet added
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Contusion, Vaccination site bruising
Clinical narrative: Severe Bruising at injection site and left leg; Severe Bruising at injection site and left leg; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (Severe Bruising at injection site and left leg) and CONTUSION (Severe Bruising at injection site and left leg) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced VACCINATION SITE BRUISING (Severe Bruising at injection site and left leg) and CONTUSION (Severe Bruising at injection site and left leg). At the time of the report, VACCINATION SITE BRUISING (Severe Bruising at injection site and left leg) and CONTUSION (Severe Bruising at injection site and left leg) outcome was unknown. Unknown    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: unknown (Inconclusive) Patient had her blood investigation done and  they were awaiting for the result.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: TCR added. Disconnected call without providing any information.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Pain in extremity
Clinical narrative: he didn't sleep well; pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (he didn't sleep well) and PAIN IN EXTREMITY (pain in arm) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 010M20A) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included HYDROCHLOROTHIAZIDE, CARVEDILOL, LISINOPRIL, ATORVASTATIN and METFORMIN for an unknown indication.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced INSOMNIA (he didn't sleep well) and PAIN IN EXTREMITY (pain in arm). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, INSOMNIA (he didn't sleep well) and PAIN IN EXTREMITY (pain in arm) outcome was unknown.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Lymph node on cervical area; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of LYMPHADENOPATHY (Lymph node on cervical area) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced LYMPHADENOPATHY (Lymph node on cervical area). At the time of the report, LYMPHADENOPATHY (Lymph node on cervical area) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication included birth control injection and unknown allergy medication.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dizziness, Fatigue, Headache, Pruritus
Clinical narrative: loss of appetite; itching; dizziness; fatigue; headache; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (loss of appetite), PRURITUS (itching), DIZZINESS (dizziness), FATIGUE (fatigue) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (loss of appetite), PRURITUS (itching), DIZZINESS (dizziness), FATIGUE (fatigue) and HEADACHE (headache). At the time of the report, DECREASED APPETITE (loss of appetite), PRURITUS (itching), DIZZINESS (dizziness), FATIGUE (fatigue) and HEADACHE (headache) outcome was unknown.            No concomitant was provided. Patient treatment information was not provided.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site reaction, Pruritus, Rash, Swelling
Clinical narrative: rash at injection site; radiating towards elbow; raised; hot; itchy; injection site was sore; injection site was hard; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (radiating towards elbow), INJECTION SITE REACTION (injection site was hard), SWELLING (raised), VACCINATION SITE WARMTH (hot) and PRURITUS (itchy) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hay fever.   On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Dec-2020, the patient experienced INJECTION SITE REACTION (injection site was hard) and INJECTION SITE PAIN (injection site was sore). On 04-Jan-2021, the patient experienced VACCINATION COMPLICATION (radiating towards elbow), SWELLING (raised), VACCINATION SITE WARMTH (hot) and PRURITUS (itchy). On 04-Feb-2021, the patient experienced RASH (rash at injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency; MELOXICAM at an unspecified dose and frequency and METHYLPREDNISOLONE at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (radiating towards elbow), INJECTION SITE REACTION (injection site was hard), SWELLING (raised), VACCINATION SITE WARMTH (hot), PRURITUS (itchy), INJECTION SITE PAIN (injection site was sore) and RASH (rash at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant products information provided    This case was linked to US-MODERNATX, INC.-MOD-2021-032970 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-032970:2nd dose vaccine
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication, Vaccination site warmth
Clinical narrative: rash at injection site; radiating towards elbow; raised; hot; itchy; injection site was sore; injection site was hard; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (radiating towards elbow), INJECTION SITE REACTION (injection site was hard), SWELLING (raised), VACCINATION SITE WARMTH (hot) and PRURITUS (itchy) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hay fever.   On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Dec-2020, the patient experienced INJECTION SITE REACTION (injection site was hard) and INJECTION SITE PAIN (injection site was sore). On 04-Jan-2021, the patient experienced VACCINATION COMPLICATION (radiating towards elbow), SWELLING (raised), VACCINATION SITE WARMTH (hot) and PRURITUS (itchy). On 04-Feb-2021, the patient experienced RASH (rash at injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency; MELOXICAM at an unspecified dose and frequency and METHYLPREDNISOLONE at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (radiating towards elbow), INJECTION SITE REACTION (injection site was hard), SWELLING (raised), VACCINATION SITE WARMTH (hot), PRURITUS (itchy), INJECTION SITE PAIN (injection site was sore) and RASH (rash at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant products information provided    This case was linked to US-MODERNATX, INC.-MOD-2021-032970 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-032970:2nd dose vaccine
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Abnormal dreams, Heart rate increased, Insomnia
Clinical narrative: Fast heart beat; Vivid dreams; Can't sleep; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Fast heart beat), ABNORMAL DREAMS (Vivid dreams) and INSOMNIA (Can't sleep) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (Fast heart beat), ABNORMAL DREAMS (Vivid dreams) and INSOMNIA (Can't sleep). At the time of the report, HEART RATE INCREASED (Fast heart beat), ABNORMAL DREAMS (Vivid dreams) and INSOMNIA (Can't sleep) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No relevant concomitant medications were reported. No treatment information was provided.    Reporter did not allow further contact